Citation: A. Trojan et al., Thalidomide: near complete regression of extramedullary bulk in refractorymultiple myeloma, SWISS MED W, 131(9-10), 2001, pp. 133-133
Citation: A. Trojan et al., Non-Hodgkin's lymphoma of the pleural cavity: late complication of artificial pneumothorax for the treatment of pulmonary tuberculosis, SWISS MED W, 131(11-12), 2001, pp. 164-164
Authors:
Trojan, A
Witzens, M
Schultze, JL
Vonderheide, RH
Harig, S
Krackhardt, AM
Stahel, RA
Gribben, JG
Citation: A. Trojan et al., Generation of cytotoxic T lymphocytes against native and altered peptides of human leukocyte antigen-A0201 restricted epitopes from the human epithelial cell adhesion molecule, CANCER RES, 61(12), 2001, pp. 4761-4765
Authors:
Harig, S
Witzens, M
Krackhardt, AM
Trojan, A
Barrett, P
Broderick, R
Zauls, AJ
Gribben, JG
Citation: S. Harig et al., Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues, BLOOD, 98(10), 2001, pp. 2999-3005
Authors:
Urosevic, M
Kurrer, MO
Kamarashev, J
Mueller, B
Weder, W
Burg, G
Stahel, RA
Dummer, R
Trojan, A
Citation: M. Urosevic et al., Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production, AM J PATH, 159(3), 2001, pp. 817-824
Authors:
Ladetto, M
Donovan, JW
Harig, S
Weller, E
Trojan, A
Poor, C
Schlossman, R
Anderson, KC
Gribben, JG
Citation: M. Ladetto et al., Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma, BIOL BLOOD, 6(3), 2000, pp. 241-253
Authors:
Trojan, A
Schultze, JL
Witzens, M
Vonderheide, RH
Ladetto, M
Donovan, JW
Gribben, JG
Citation: A. Trojan et al., Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies, NAT MED, 6(6), 2000, pp. 667-672